St. James Investment Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-620,098
Closed -$36.6M 31
2021
Q4
$36.6M Sell
620,098
-50,530
-8% -$2.5M 5.28% 3
2021
Q3
$28.8M Sell
670,628
-54,331
-7% -$2.41M 4.22% 6
2021
Q2
$28.4M Sell
724,959
-53,937
-7% -$2.1M 3.38% 8
2021
Q1
$28.2M Sell
778,896
-50,400
-6% -$1.79M 3.74% 9
2020
Q4
$30.5M Sell
829,296
-18,933
-2% -$694K 3.94% 8
2020
Q3
$29.5M Sell
848,229
-47,783
-5% -$1.68M 4.1% 9
2020
Q2
$27.8M Buy
896,012
+616,483
+221% +$20.9M 4.25% 9
2020
Q1
$8.66M Buy
+279,529
New +$9.52M 1.09% 28

Other funds holding PFE

St. James Investment Company's PFE Position: Q1 2022 in Review

St. James Investment Company sold out of Pfizer (PFE) in Q1 2022, closing a stake of 620,098 shares — an estimated $36.6M sold.

St. James Investment Company first reported a position in PFE in Q1 2020 and held it in 8 quarters. The position peaked at $36.6M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • St. James Investment Company reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • St. James Investment Company sold 620,098 Pfizer shares in Q1 2022, an estimated $36.6M.
  • St. James Investment Company first reported a position in Pfizer in Q1 2020 and held it in 8 quarters.
  • St. James Investment Company's Pfizer position peaked at $36.6M in Q4 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on St. James Investment Company's 13F filing for Q1 2022, filed 4 May 2022.